On 18 September 2026, SHENYANG PUBLIC (00747.HK) announced the disposal of 100% equity interest in the target company, Shenzhen Jusheng Chuangjian Investment Development Co., Ltd., to Shenzhen Chengb Castle Century Trading Co., Ltd. at a consideration of RMB 2,000,000, with the purchaser wholly owned by Zhang Zehao.
This week's Going Global Weekly with mainland enterprises' Hong Kong listings and pharma globalisation forming the two main lines. On the financing side, TRANSSION, RED AVENUE NEW MATERIALS, ROBOTECHNIK and Junxin Environmental Protection passed the Hong Kong Stock Exchange listing hearing, CCTECH and SKYCHEM TECHNOLOGY advanced their H-share plans, Nazhen Technology launched its global offering with net fundraising of up to approximately HK$6.296 billion, and FORMS SYNTRON announced a delayed listing with refunds; on the pharma side, GENFLEET-B, LEADS BIOLABS-B and CSPC PHARMA released clinical data at WCLC, IMPACT THERAP-B received a positive opinion from CHMP, and GENSCRIPT BIO reached a wet laboratory services cooperation with the Lilly TuneLab platform.
On 18 September 2026, TRANSTHERA-B (02617.HK) announced that its self-developed Jeentai® (tinengotinib) has been included in the CSCO Guidelines for the Diagnosis and Treatment of Biliary Tract Malignancies as a Class II recommendation, category 2A, for advanced biliary tract malignancies.
On 18 September 2026, IMPACT THERAP-B (07630.HK) announced that the CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of sepalna (Sepalna®) for the maintenance treatment of advanced epithelial ovarian, fallopian tube and primary peritoneal cancer, with the application to be submitted to the European Commission for a final decision.
On 18 September 2026, CISI FIN (06058.HK) announced that its indirectly wholly-owned subsidiary CISI Investment disposed of notes with an aggregate principal amount of USD 20,150,000 in the open market between 15 June and 17 September 2026 at a total consideration of approximately USD 20,080,767.
On 18 September 2026, S HARBOURHOLD (01663.HK) announced that its chairman and substantial shareholder Wang Linbing acquired a total of 3,890,000 ordinary shares in the open market at an average price of approximately HKD 0.056 per share.
On September 18, 2026, the three major Hong Kong stock indices rebounded collectively, with the Hang Seng Index up 0.60%, the Hang Seng TECH Index surging 2.20%, and the Hang Seng China Enterprises Index up 0.61%. The Hang Seng Index's full-day total market turnover was 266.5 billion HKD. On the board, among Stock Connect constituent stocks, XIZHI TECH-P soared 22.61%, with some optical communications concept stocks moving higher.
On September 18, 2026, the three major Hong Kong indices rebounded collectively, with the Hang Seng Index up 0.60%, the Hang Seng TECH Index surging 2.20%, and the Hang Seng China Enterprises Index up 0.61%. The Hang Seng Index's full-day total market turnover was 266.5 billion HKD, Southbound funds saw a net inflow of 1.193 billion HKD.
On 18 September 2026, LIAONING PORT (02880.HK) announced that its wholly-owned subsidiary DBR will acquire the container ship "Jifa Beihai" from Dalian Port Wantong Logistics for RMB 81,613,572.00, a connected transaction.
On 18 September 2026, Shenzhen Transsion Holdings Co., Ltd. (688036.SH) announced that the Listing Committee of HKEX held a listing hearing on 17 September 2026 to consider its application for the issue of overseas-listed foreign shares (H shares) and listing on the Main Board of HKEX, and that its sponsor received a letter from HKEX on 18 September 2026 stating that the Listing Committee has reviewed its listing application.
On 18 September 2026, SHANDONG XINHUA (00719.HK) disclosed that it recently obtained the drug registration certificate for levocarnitine oral solution issued by the National Medical Products Administration.
On 18 September 2026, C FIN SERVICES (00605.HK) announced that its wholly-owned subsidiary Shenzhen Lingda Microcredit granted a one-year loan of RMB 19,000,000 at 15.6% per annum to the borrower Customer GQ.
on September 18, 2026, the three major Hong Kong indices rebounded collectively, with the Hang Seng Index up 0.60%, the Hang Seng TECH Index surging 2.20%, and the Hang Seng China Enterprises Index up 0.61%. The Hang Seng Index's full-day total market turnover was 266.5 billion HKD, Southbound funds saw a net inflow of 1.193 billion HKD.
On 18 September 2026, Elate Holdings Limited (00076.HK) announced that its wholly-owned subsidiary Comp Media & Advertising Limited has entered into a Memorandum of Understanding with Guangdong Hai Shang Yun Tian Media Group Limited to jointly organise the "Macao International AI Film Incubation Festival" and to collaborate on an AI-generated science fiction film, including its screening and overseas distribution.
The 6.7604 million H shares held collectively by 21 cornerstone investors of SIGENERGY (06656.HK) will see their lock-up period end on October 15, 2026, with the shares officially unlocked from October 16, representing a market value of approximately HKD 2.192 billion at the offer price.
On September 18, 2026, tech growth themes rebounded across the board in the HK shares ETFs market. E Fund (HK) Solactive Asia Semiconductor Select Index ETF led with a 4.91% gain, while Bosera SZSE ChiNext Daily (2x) Leveraged Product, CSOP Solactive Asia AI Bottleneck Index ETF, Global X China Semiconductor ETF and Premia China STAR50 ETF each rose more than 4%, with semiconductor, artificial intelligence and ChiNext directions strengthening in a concentrated fashion. On the downside, Japan themes and dividend products pulled back modestly, with Global X K-Pop and Culture ETF down 2.26% to lead the decliners and overall losses limited. Among southbound Stock Connect ETFs, tech themes rose broadly, with CSOP FTSE HK-Korea Tech+ Index ETF up 3.67% to lead and three Hang Seng TECH-related ETFs each gaining more than 2%; high-dividend and dividend products edged lower.
